WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
Reversing a longstanding policy, the U.S. federal government has ruled in a legal brief that human and other genes should not be eligible for patents. This could have an enormous impact on medicine and on the biotechnology industry.
It is not yet clear if the new policy will be put into effect by the Patent Office. If it is, it is likely to draw protests from biotechnology companies.